Oxycodone hydrochloride regulatory update

FDA’s Anesthetic and Analgesic Drug Products and Drug Safety and Risk Management advisory committees will hold a joint meeting on Sept. 10 to discuss an NDA for an abuse-deterrent formulation of oxyco...